Tributary Capital Management LLC increased its stake in LHC Group, Inc. (NASDAQ:LHCG) by 7.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 252,356 shares of the health services provider’s stock after acquiring an additional 17,189 shares during the quarter. LHC Group makes up 2.0% of Tributary Capital Management LLC’s holdings, making the stock its 6th largest holding. Tributary Capital Management LLC owned about 0.81% of LHC Group worth $25,990,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Scout Investments Inc. lifted its position in shares of LHC Group by 2.2% in the third quarter. Scout Investments Inc. now owns 62,464 shares of the health services provider’s stock worth $6,433,000 after buying an additional 1,336 shares during the last quarter. Campbell Newman Asset Management Inc. acquired a new stake in shares of LHC Group in the third quarter worth about $571,000. Bank of Montreal Can lifted its position in shares of LHC Group by 55.7% in the third quarter. Bank of Montreal Can now owns 3,864 shares of the health services provider’s stock worth $398,000 after buying an additional 1,383 shares during the last quarter. Summit Creek Advisors LLC lifted its position in shares of LHC Group by 7.4% in the third quarter. Summit Creek Advisors LLC now owns 191,102 shares of the health services provider’s stock worth $19,682,000 after buying an additional 13,180 shares during the last quarter. Finally, United Services Automobile Association lifted its position in shares of LHC Group by 122.9% during the 2nd quarter. United Services Automobile Association now owns 7,578 shares of the health services provider’s stock worth $649,000 after purchasing an additional 4,178 shares during the last quarter. Institutional investors and hedge funds own 86.50% of the company’s stock.
Several equities analysts recently weighed in on the company. Robert W. Baird boosted their price objective on LHC Group from $95.00 to $98.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Jefferies Financial Group boosted their price objective on LHC Group to $120.00 and gave the stock a “buy” rating in a research report on Friday, August 3rd. William Blair reissued a “buy” rating on shares of LHC Group in a research report on Thursday, November 1st. Finally, Royal Bank of Canada boosted their price objective on LHC Group to $101.00 and gave the stock a “sector perform” rating in a research report on Friday, August 3rd. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $105.64.
In related news, SVP Jeff Reibel sold 1,921 shares of the stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $94.12, for a total transaction of $180,804.52. Following the sale, the senior vice president now directly owns 8,125 shares in the company, valued at approximately $764,725. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the sale, the chief executive officer now owns 200,765 shares in the company, valued at $19,092,751.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 79,677 shares of company stock worth $7,587,030. Corporate insiders own 6.80% of the company’s stock.
LHC Group stock traded up $0.14 during trading hours on Friday, hitting $96.93. The stock had a trading volume of 167,594 shares, compared to its average volume of 388,613. LHC Group, Inc. has a fifty-two week low of $58.65 and a fifty-two week high of $103.79. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of 40.05, a price-to-earnings-growth ratio of 1.67 and a beta of 0.80. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, meeting the consensus estimate of $0.95. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The company had revenue of $507.00 million for the quarter, compared to analyst estimates of $515.03 million. During the same period in the prior year, the company posted $0.64 EPS. The company’s revenue was up 88.0% compared to the same quarter last year. On average, analysts expect that LHC Group, Inc. will post 3.52 earnings per share for the current fiscal year.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
See Also: What are CEFs?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.